AID systems were associated with varying glycemic outcomes in type 1 diabetes, with MiniMed 780G users demonstrating best time in range.
One question, in light of FREEDOM, is how well new DES compare with CABG in patients with diabetes and multivessel disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback